About this trial
This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Chronic Pressure Ulcers
Eligibility criteria
Qualifiers
Male or Female, 18 years of age or older
Subject has a medical diagnosis of Pressure Injury/Ulcer located on the pelvis or lower extremity
Subject has a Pressure Injury/Ulcer Stage 2 or 3 without infection
Index ulcer is a minimum of 1cm2 and a maximum of 30cm2 at first treatment visit
Disqualifiers
Subject has a known life expectancy of <1 year
Subject is unable to comply with protocol treatment
Subject has major uncontrolled medical disorders in the opinion of the investigator, such as serious cardiovascular, renal, liver, pulmonary, autoimmune, palliative care, or inherited blood disorders that may affect wound healing in the opinion of the investigator
Subject actively being treated for malignant disease or history of malignancy or radiation therapy at the site of wound
Trial design
Treatments tested in this trial
- NeoThelium FT (HCT/P 361)
Treatment groups
Sponsors and collaborators
NuScience Medical Biologics, LLC
Lead sponsor
SygNola, LLC
Collaborator